Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
KYORIN Pharmaceutical Co.,Ltd. ( (JP:4569) ) has issued an announcement.
KYORIN Pharmaceutical Co., Ltd. reported significant growth in its financial performance for the three months ended June 30, 2025, with net sales increasing by 6.4% and operating profit surging by 106% compared to the same period last year. Despite the positive quarterly results, the company forecasts a decline in full-year profits, indicating potential challenges ahead.
More about KYORIN Pharmaceutical Co.,Ltd.
KYORIN Pharmaceutical Co., Ltd. is a company operating in the pharmaceutical industry, focusing on the development and sale of pharmaceutical products. The company is listed on the Tokyo Stock Exchange and is led by President and CEO Yutaka Ogihara.
Average Trading Volume: 97,425
Technical Sentiment Signal: Hold
Current Market Cap: Yen80.28B
For detailed information about 4569 stock, go to TipRanks’ Stock Analysis page.